preclinical study

Cambridge, Massachusetts, September 9, 2026 MetaVia Inc., a clinical-stage biotechnology company focused on cardiometabolic diseases, has reported new preclinical...

HOUSTON, August 18, 2026 FibroBiologics, Inc., a clinical-stage biotechnology company developing therapies based on fibroblast cells and fibroblast-derived materials,...

Ramat Gan, Israel — August 17, 2026 Can-Fite BioPharma Ltd. announced new preclinical findings showing that namodenoson enhanced the...

Cambridge, Massachusetts, August 17, 2026 Insilico Medicine, a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced...

Boston, Massachusetts, August 17, 2026 PhaseV, an artificial intelligence and machine learning company focused on clinical development, has announced...

Ramat Gan, Israel, August 17, 2026 Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and oncology...

LEHI, Utah, August 6, 2026 CancerVax announced a significant preclinical milestone with new in vitro findings demonstrating that its...

MELBOURNE, Australia, August 6, 2026 Propanc Biopharma announced compelling preclinical and early translational findings for its lead investigational therapy...

MELBOURNE, Australia, July 30, 2026 Amplia Therapeutics announced the online publication of comprehensive preclinical findings evaluating narmafotinib in pancreatic...

Hong Kong, July 27, 2026 Ascletis Pharma Inc. announced that its investigational ASC37, a next-generation GLP-1R/GIPR/GCGR triple peptide agonist,...